Clinical trial

Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients…

NCT01041001 · Medipost Co Ltd., Industry · Completed

Key facts

NCT number NCT01041001
Title Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury
Official title Randomized, Open-Label, Multi-Center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect
Lead sponsor Medipost Co Ltd., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cartilage Injury, Osteoarthritis
Intervention type Biological, Procedure
Interventions Cartistem, Microfracture treatment
Enrollment 104
Start date Feb 1, 2009
Primary completion Dec 1, 2010
Completion Jan 1, 2011
First posted Dec 30, 2009
Last update posted Apr 20, 2017
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies